Leiden Academic Centre for Drug Research
Master Bio-Pharmaceutical Sciences
This page provides information to support your application for the Master's programme of Bio-Pharmaceutical Sciences.
Application procedure: the application letter
All applicants for the MSc programme are required to write an application letter. In this letter you need to provide a detailed motivation to support your choice for the specific research area and corresponding LACDR-division (Which falls under a cluster) in which you would like to follow your Research Project 1.
To provide you with a suitable overview of the wide range of research-areas, we have arranged the Research themes of the LACDR clusters below.
Important if you wish to apply:
You are required to provide an application letter. This is very important, and requires two very essential elements:
- Firstly, it is paramount to include within your letter of application a very detailed and specific motivation which clearly supports your choice of LACDR research area.
- Secondly, you need to provide a detailed and excellent motivation of why this choice is logically supported by your previous research experience.
For general information on how to apply for the Master's programme of Bio-Pharmaceutical Sciences, please check our information-website for our master's programme >>
For more specific information on how to apply, including detailed questions on the process of application, please contact:
- Dr. Diana Klomp
Study-coordinator for the Master's programme
- Bachelor's students of Bio-Pharmaceutical Sciences are strongly advised to check the information and "Stappenplan" that is available on Blackboard
LACDR Research areas for your orientation:
Below we have listed the Research Themes offered by the LACDR Clusters, in the context of the Master's programme:
- Development of Comprehensive and High-throughput metabolomics techniques
- Highly sensitive analysis using 3D cell culture model
- Macrophages and atherosclerotic lesions
- Immunotherapy to limit atherosclerosis
- Therapeutic intervention to enhance atherosclerotic plaque stability
Drug Delivery Technology
Drug & Target Discovery
- Novel Receptor Concepts
- Better ligands for G Protein-Coupled Receptors
For general information about the division, please contact:
Anneke Poels (Cluster Secretariat)